Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4·5 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trialPeter Mitchell, Justin Whitley, Henry Ma et al.|The Lancet|2022Cited by 225
Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trialMark Parsons, Vignan Yogendrakumar, Leonid Churilov et al.|The Lancet Neurology|2024Cited by 89
Tenecteplase Improves Reperfusion across Time in Large Vessel StrokeVignan Yogendrakumar, James Beharry, Leonid Churilov et al.|Annals of Neurology|2022Cited by 38
Tenecteplase Treatment and Thrombus Characteristics Associated With Early Reperfusion: An EXTEND-IA TNK Trials AnalysisVignan Yogendrakumar, David Leggett, Leonid Churilov et al.|Stroke|2023Cited by 32
Safety and Efficacy of Tenecteplase in Older Patients With Large Vessel OcclusionVignan Yogendrakumar, Benjamin Clissold, Leonid Churilov et al.|Neurology|2022Cited by 23